**Core Concept:**
The question is asking about the contraindications of first-line anti-tuberculosis medications during pregnancy. First-line tuberculosis medications include isoniazid, rifampicin, pyrazinamide, and ethambutol. These drugs are essential for the treatment of tuberculosis but may pose risks to the developing fetus.

**Why the Correct Answer is Right:**
The correct answer, **Isoniazid**, is contraindicated in pregnancy due to its potential to cause severe fetal harm, including neural tube defects, congenital abnormalities, and developmental delays. Isoniazid crosses the placenta and accumulates in fetal tissues, leading to these adverse effects.

**Why Each Wrong Option is Incorrect:**
A. **Rifampicin**: Although rifampicin has been associated with some neonatal toxicity, it is generally considered safe during the second and third trimesters. However, it should be used with caution during the first trimester, and the benefits should be weighed against the risks.

B. **Pyrazinamide**: Pyrazinamide is considered safe during pregnancy, although it is recommended to avoid it during the first trimester due to the potential for teratogenic effects.

C. **Ethambutol**: Ethambutol is generally considered safe during pregnancy, although it should be used cautiously during the first trimester due to the risk of ocular toxicity in the newborn.

**Clinical Pearl / High-Yield Fact:**
During tuberculosis treatment, a safer alternative to isoniazid is pyrazinamide or ethambutol. These drugs have a lower risk of causing fetal harm compared to isoniazid. Health care providers should carefully evaluate the benefits and risks of each drug choice and monitor the mother and newborn closely for any adverse effects.

**Correct Answer Explanation:**
The correct answer, **Isoniazid**, is contraindicated due to its potential to cause severe fetal harm. In contrast, pyrazinamide and ethambutol have lower risks for causing fetal harm and can be considered safer alternatives during pregnancy.